title: Assessment of correlation between in vitro CD3+ T cell susceptibility to EAV infection and clinical outcome following experimental infection.
abstract: In a recent study, we demonstrated that the virulent Bucyrus strain (VBS) of EAV could infect in vitro a small population of CD3(+) T lymphocytes from some but not all horses. Furthermore, we have shown that a common haplotype is associated with this in vitro CD3(+) T cell susceptibility/resistance phenotype to EAV infection. In this study, we investigated whether the differences in the susceptibility or resistance of CD3(+) T cells in vitro correlate with the outcome and severity of clinical signs in vivo. Thus, horses were divided into two groups based on their CD3(+) T cell susceptible or resistant phenotype. Following experimental inoculation with the recombinant VBS of EAV, horses were assessed for presence and severity of clinical signs, duration and magnitude of virus shedding, as well as production of proinflammatory and immunomodulatory cytokines in peripheral blood mononuclear cells using real-time quantitative RT-PCR. The data showed that there was a significant difference between the two groups of horses in terms of cytokine mRNA expression and evidence of increased clinical signs in horses possessing the in vitro CD3(+) T cell resistant phenotype. This is the first study to provide direct evidence for a correlation between variation in host genotype and phenotypic differences in terms of the extent of viral replication, presence and severity of clinical signs and cytokine gene expression caused by infection with virulent EAV.
authors.affiliation: Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
authors.forename: Yun Young
authors.initials: YY
authors.lastname: Go
authors.forename: R Frank
authors.initials: RF
authors.lastname: Cook
authors.forename: Juliana Q
authors.initials: JQ
authors.lastname: Fulgêncio
authors.forename: Juliana R
authors.initials: JR
authors.lastname: Campos
authors.forename: Pamela
authors.initials: P
authors.lastname: Henney
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Timoney
authors.forename: David W
authors.initials: DW
authors.lastname: Horohov
authors.forename: Udeni B R
authors.initials: UB
authors.lastname: Balasuriya
mesh_terms: D000818:Animals; D018174:Arterivirus Infections / Q000235:genetics / Q000276:immunology / Q000662:veterinary*; D017252:CD3 Complex / Q000235:genetics / Q000276:immunology; D016207:Cytokines / Q000235:genetics / Q000276:immunology; D004198:Disease Susceptibility; D007240:Equartevirus / Q000276:immunology / Q000472:pathogenicity*; D005260:Female; D006239:Haplotypes; D006734:Horse Diseases / Q000235:genetics / Q000276:immunology* / Q000821:virology; D006736:Horses / Q000276:immunology* / Q000821:virology; D007113:Immunity, Innate / Q000235:genetics; D007963:Leukocytes, Mononuclear / Q000276:immunology; D018655:Lymphocyte Count; D010641:Phenotype; D013601:T-Lymphocytes / Q000276:immunology*; D017201:Virus Shedding
chemical_list: D017252:CD3 Complex; D016207:Cytokines